Company intelligence / Profile preview

Davion Healthcare

Cork, Ireland

Ownership: Public · DAVI
Development stage: Other

Overview

BreastCheck is a commercial FDA-registered Class I home testing device for breast anomalies, including potential cancers, offering immediate results. Early clinical results support feasibility and regulatory approval; global partnerships for distribution are in place

Therapeutic areas: OncologyWomen's Health
Modalities: Device
Industry: Medical Imaging

Partnerships

NeuRX Health Inc (global manufacturing and distribution of BreastCheck; $120M license agreement + ongoing royalties)

Beyond the preview

Go deeper on Davion Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Davion Healthcare.

Explore the full profile